Effect of thromboxane A2 antagonists on bronchial hyperresponsiveness induced immediately after interleukin-8 inhalation in guinea-pigs

Br J Pharmacol. 1997 Nov;122(6):1015-20. doi: 10.1038/sj.bjp.0701478.

Abstract

1. Although repeated intranasal administration of interleukin-8 (IL-8) causes bronchial hyperresponsiveness (BHR) mediated via thromboxane A2 (TXA2) and airway neutrophil accumulation in guinea-pigs, the acute effect of inhaled IL-8 is unclear. We performed this study to clarify the acute effect of IL-8 on bronchial responsiveness and the role of TXA2. 2. The effects of inhaled IL-8 on bronchial responsiveness and of the TXA2 antagonists, S-1452 (0.01 and 0.1 mg kg-1) and ONO-NT-126 (1.0 or 10 micrograms kg-1), on IL-8-induced BHR were examined by use of a modified Konzett-Rössler method in guinea-pigs. 3. Inhaled IL-8 at 100 ng ml-1, which failed to induce significant changes in Pao (pressure at the airway opening), enhanced an increase in Pao induced by subsequent inhalations of ascending doses (50-200 micrograms ml-1) of methacholine and histamine, suggesting the potentiating effect of IL-8 on bronchial responsiveness. No significant leukocyte infiltration was observed histologically sixteen minutes after the IL-8 inhalation. Both S-1452 and ONO-NT-126 reduced the IL-8-induced BHR. 4. In conclusion, IL-8 rapidly causes BHR via TXA2 release in guinea-pigs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Animals
  • Bridged Bicyclo Compounds / pharmacology
  • Bronchial Hyperreactivity / chemically induced*
  • Fatty Acids, Monounsaturated / pharmacology
  • Guinea Pigs
  • Interleukin-8 / administration & dosage
  • Interleukin-8 / antagonists & inhibitors
  • Interleukin-8 / pharmacology*
  • Male
  • Prostaglandin Antagonists / pharmacology
  • Terfenadine / pharmacology
  • Thromboxane A2 / antagonists & inhibitors*

Substances

  • Bridged Bicyclo Compounds
  • Fatty Acids, Monounsaturated
  • Interleukin-8
  • Prostaglandin Antagonists
  • S 145
  • Thromboxane A2
  • Terfenadine